SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

21626 reported adverse events

Drug classes: Dipeptidyl Peptidase 4 Inhibitor [EPC]

These side effects are most commonly reported by patients taking SITAGLIPTIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 1511
1 DIARRHOEA 1398
2 NAUSEA 1111
3 DRUG INEFFECTIVE 1008
4 FATIGUE 902
5 ACUTE KIDNEY INJURY 838
6 VOMITING 781
7 WEIGHT DECREASED 718
8 DIZZINESS 639
9 PANCREATITIS 626
See all common reactions for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOCARCINOMA PANCREAS 104 0.0809
1 PANCREATIC CARCINOMA METASTATIC 212 0.0745
2 PANCREATICODUODENECTOMY 45 0.0678
3 DIABETIC METABOLIC DECOMPENSATION 39 0.0281
4 DIABETES MELLITUS INADEQUATE CONTROL 423 0.0239
5 PANCREATITIS CHRONIC 56 0.0236
6 PANCREATIC CARCINOMA 588 0.0203
7 DIABETIC COMPLICATION 51 0.0200
8 LACTIC ACIDOSIS 566 0.0175
9 METASTASES TO PERITONEUM 40 0.0158
See all enriched reactions for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE